Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now early-phase tilt small index

Cushing Disease: early-phase trial registry

7 of 9 indexed Cushing Disease trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 7 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Cushing Disease: 9 US clinical trials tracked, 7 recruiting.

Cushing Disease is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), running 2 of these trials.

Enrollment posture brief

Registry condition cushing-disease

OPEN 7 | RECR 78% | LATE 1 | EARLY 4 | RANK #1916 | SPON 2

Nearest open-share peer: Advanced Colorectal Carcinoma (78% recruiting · 9 trials)

Cushing Disease (this)78%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Cushing Disease

Cushing Disease lists 7 open slots (78% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cushing Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cushing Disease is recruiting above its size-band peers.

    7 of 9 indexed trials (77.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cushing Disease research.

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cushing Disease enrolment sits around 51 participants.

    Median target enrolment is 51 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.

  4. Cushing Disease splits between interventional and observational designs.

    5 interventional and 4 observational studies make up this index (55.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 23Phase 31

Open and recent trials

9 total, page 1 of 1

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 3
Phase 3 1

Named interventions

Most-linked intervention names on Cushing Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Levoketoconazole Drug
1 trials
Fimepinostat Drug
1 trials
LCI699 Drug
1 trials
Non-Contrast Ultrasound Diagnostic test
1 trials
Contrast enhanced ultrasound Diagnostic test
1 trials
Contrast enhanced pituitary magnetic resonance imaging (MRI) Diagnostic test
1 trials
Seliciclib Drug
1 trials
Barratt's Impulsivity Scale (BIS) Other
1 trials

US sites by state

Facility locations filed on Cushing Disease trials. A trial with sites in several states counts in each.

Maryland 3 trials
Oregon 2 trials
Ohio 2 trials
New York 2 trials
California 2 trials
New Mexico 1 trials
New Jersey 1 trials
Missouri 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cushing Disease page

9 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cushing Disease condition card totals 9 registered trials; most-linked intervention Levoketoconazole; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.